68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients
CompletedOBSERVATIONAL
Enrollment
31
Participants
Timeline
Start Date
January 31, 2024
Primary Completion Date
March 31, 2025
Study Completion Date
August 10, 2025
Conditions
Nasopharyngeal Cancer
Trial Locations (1)
Unknown
The First Affiliated Hospital of Xiamen University, Xiamen
All Listed Sponsors
lead
The First Affiliated Hospital of Xiamen University
OTHER
NCT07139054 - 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients | Biotech Hunter | Biotech Hunter